Novartis Ag (NVS) Cash from Discontinued Operations (2013 - 2023)

Novartis Ag (NVS) has 7 years of Cash from Discontinued Operations data on file, last reported at 648000000.0 in Q4 2023.

• Quarterly Cash from Discontinued Operations rose 88.92% year-over-year to 648000000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 886000000.0 (up 12.29% YoY) and the FY2023 annual result came in at 238000000.0, down 80.12% from the prior year.
• Cash from Discontinued Operations advanced to 648000000.0 in Q4 2023 per NVS's latest filing, from 74000000.0 in the prior quarter.
• The five-year high for Cash from Discontinued Operations was 648000000.0 in Q4 2023, with the low at 59000000.0 in Q2 2023.
• Average Cash from Discontinued Operations over 3 years is 281500000.0, with a median of 224000000.0 recorded in 2022.
• The widest YoY moves for Cash from Discontinued Operations: up 88.92% in 2023, down 83.41% in 2023.
• Novartis Ag's Cash from Discontinued Operations stood at 499000000.0 in 2019, then plunged by 31.26% to 343000000.0 in 2022, then surged by 88.92% to 648000000.0 in 2023.
• Business Quant data shows NVS's Cash from Discontinued Operations at 648000000.0 in Q4 2023, 74000000.0 in Q3 2023, and 59000000.0 in Q2 2023.